PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Symptom | C0030293|pancreatic insufficiency |
| Sentences | 17 |
| PubMedID- PMC4406118 | She also had pancreatic insufficiency consistent with cystic fibrosis. |
| PubMedID- 21632288 | Efficacy and safety of pancreaze(r) for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. |
| PubMedID- 21086085 | Exocrine pancreatic insufficiency (epi) is associated with conditions including cystic fibrosis (cf), chronic pancreatitis (cp), and pancreatic surgery (ps). |
| PubMedID- 24642012 | A sweat test excluded cystic fibrosis as the cause of the pancreatic insufficiency. |
| PubMedID- 23497549 | A 25 years old university graduate student diagnosed of cystic fibrosis with pancreatic insufficiency in childhood was started deteriorating clinically due to uncontrolled infection in chest, not responding to multiple courses of various intravenous antibiotics over 6 months. |
| PubMedID- 24091606 | Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency. |
| PubMedID- 22922373 | Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis. |
| PubMedID- 23613005 | We analyzed mri and mrcp in 28 patients (15 f, range: 1 year–19 years) performed for suspected pancreatitis (n = 6), hyperamylasemia (n = 7), pancreatic insufficiency in patients with cystic fibrosis (n = 3), pancreatic insufficiency (n = 4), recurrent pancreatitis (n = 8). |
| PubMedID- 20171415 | Background: pancreatic enzyme replacement therapy (pert) is essential for maintaining adequate nutrition in children with exocrine pancreatic insufficiency (epi) due to cystic fibrosis (cf). |
| PubMedID- 20150178 | cystic fibrosis is associated with pancreatic insufficiency and acidic intraluminal conditions that limit the action of pancreatic enzyme replacement therapy, especially that of lipase. |
| PubMedID- 22567777 | What is the current fda-approved therapy to treat pancreatic insufficiency for children with cystic fibrosis. |
| PubMedID- 21342076 | Research design and methods: patients with exocrine pancreatic insufficiency due to cystic fibrosis (cf) who had previously taken high doses of pancreatic enzymes received pancreatin 40,000 capsules (creon 40,000 minimicrospheres, abbott gmbh, hanover, germany) as part of their normal treatment for up to 2 years. |
| PubMedID- 25066363 | Safety and efficacy of creon(r) micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. |
| PubMedID- 25050848 | Long-term experience with zenpep in infants with exocrine pancreatic insufficiency associated with cystic fibrosis. |
| PubMedID- 24743047 | Background: pancreatic insufficiency is common in patients with cystic fibrosis (cf) and leads to malabsorption of fat-soluble vitamins. |
| PubMedID- 20441244 | Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (creon) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. |
| PubMedID- 21209163 | High rate of exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency. |
Page: 1